Center for Scientific Review; Notice of Closed Meetings, 52356-52357 [2010-21085]
Download as PDF
<![CDATA[
52356
Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices
in authoring the action agenda. The
Leadership Council’s draft action
agenda is anticipated to be available for
public review and comment in
December 2010. Work group reports will
be appended to the action agenda.
For more information on National
Conversation work groups, including
their charges and meeting summaries,
visit this Web site: https://
www.atsdr.cdc.gov/
nationalconversation/
work_groups.html.
For additional information on the
National Conversation on Public Health
and Chemical Exposures, visit this Web
site: https://www.atsdr.cdc.gov/
nationalconversation/.
Dated: August 18, 2010.
Tanja Popovic,
Deputy Associate Director for Science Centers
for Disease Control and Prevention.
[FR Doc. 2010–21120 Filed 8–24–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
srobinson on DSKHWCL6B1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: National Human
Immunodeficiency Virus (HIV)
Behavioral Surveillance, Funding
Opportunity Announcement PS11–001;
Initial Review
Correction: This notice was published
in the Federal Register on August 4,
2010, Volume 75, Number 149, page
46952. The time and date should read
as follows:
Time and Date: 8 a.m.–5 p.m.,
October 4, 2010 (Closed).
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, GA 30333, Telephone: (404)
498–2293.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: August 18, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. C1–2010–21185 Filed 8–24–10; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
17:48 Aug 24, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Diabetes
Immunology Ancillary Studies.
Date: October 7, 2010.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call)
Contact Person: D.G. Patel, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
756, 6707 Democracy Boulevard, Bethesda
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Diabetes
Epidemiology Ancillary Study.
Date: October 13, 2010.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda MD 20892. (Telephone
Conference Call)
Contact Person: D.G. Patel, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
756, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Review of R24
Applications.
Date: October 27, 2010.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: D.G. Patel, PhD, Scientific
Review Officer, Review Branch, DEA,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
NIDDK, National Institutes of Health, Room
756, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21090 Filed 8–24–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cardioprotection, Remodeling and
Collateral Circulation.
Date: September 8–9, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Lawrence E. Boerboom,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130,
MSC 7814, Bethesda, MD 20892, (301) 435–
8367, boerboom@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Reproduction and Metabolism.
Date: September 29–30, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\25AUN1.SGM
25AUN1
Federal Register / Vol. 75, No. 164 / Wednesday, August 25, 2010 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Sooja K Kim, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182,
MSC 7892, Bethesda, MD 20892, (301)
435–1780, kims@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 19, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21085 Filed 8–24–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biomarker.
Date: September 15, 2010.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Sally A. Mulhern, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
5877, mulherns@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: September 29–30, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
17:48 Aug 24, 2010
Jkt 220001
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Weihua Luo, MD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: September 30–October 1, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Estina E. Thompson, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–496–
5749, thompsone@mail.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Molecular Pathobiology Study
Section.
Date: October 4–5, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Manzoor Zarger, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Language and Communication Study
Section.
Date: October 4–5, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Weijia Ni, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3184, MSC 7848, Bethesda, MD
20892, (301) 237–9918, niw@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—A Study Section.
Date: October 4–5, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Baltimore Marriott Waterfront, 700
Aliceanna Street, Baltimore, MD 21202.
Contact Person: Joanna M. Pyper, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301) 435–
1151, pyperj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative: Emotion, Stress, and Health.
Date: October 5, 2010.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
52357
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Harbor Magic—Pier 5 Hotel, 711
Eastern Avenue, Baltimore, MD 21202.
Contact Person: Maribeth Champoux, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892, 301–594–
3163, champoum@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 19, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21084 Filed 8–24–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Comment: National Center
for Complementary and Alternative
Medicine Draft Strategic Plan
ACTION:
Notice.
The National Center for
Complementary and Alternative
Medicine (NCCAM) is developing its
third strategic plan and invites the
public to provide comments on a draft.
The draft will be publicly available
through the NCCAM Web site at
https://nccam.nih.gov from on or about
August 30 through September 30, 2010.
The public is invited to provide
comments through the NCCAM Web
site.
Background: The National Center for
Complementary and Alternative
Medicine (NCCAM) was established in
1998 with the mission of exploring
complementary and alternative healing
practices in the context of rigorous
science, training CAM researchers, and
disseminating authoritative information
to the public and professionals.
To date, NCCAM’s efforts to
rigorously study CAM, to train CAM
researchers, and to communicate with
the public and professionals, have been
guided by NCCAM’s previous strategic
plans, located on the NCCAM Web site
at https://nccam.nih.gov/about/plans.
The public is invited to review the
draft of its third strategic plan and
provide comments from August 30
through September 30, 2010. The papers
may be viewed at https://
nccam.nih.gov/.
SUMMARY:
E:\FR\FM\25AUN1.SGM
25AUN1
]]>Agencies
[Federal Register Volume 75, Number 164 (Wednesday, August 25, 2010)]
[Notices]
[Pages 52356-52357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21085]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cardioprotection, Remodeling and Collateral
Circulation.
Date: September 8-9, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: Lawrence E. Boerboom, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130, MSC 7814, Bethesda, MD
20892, (301) 435-8367, boerboom@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Reproduction and Metabolism.
Date: September 29-30, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
[[Page 52357]]
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: Sooja K Kim, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD 20892, (301) 435-
1780, kims@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 19, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-21085 Filed 8-24-10; 8:45 am]
BILLING CODE 4140-01-P
